Treatment of corticosteroid-resistant ulcerative colitis with oral low molecular weight heparin

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 5, Issue 5

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

182

HTML

1936

Tables (1-3)

187

Sum=2305

Oct 15, 1999 (publication date) through Aug 31, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Reports

World J Gastroenterol. Oct 15, 1999; 5(5): 448-450
Published online Oct 15, 1999. doi: 10.3748/wjg.v5.i5.448

Table 2 Effects of oral LMWH on CD_62P and CD₆₃, TXA₂, platelet aggregation rate (PAR) and thrombosis length (TL) in vitro in UC patients (x^-± s)

^aP < 0.05,

^bP < 0.01 vs normal person;

^dP < 0.01 vs pretreatment.

Citation: Cui HF, Jiang XL. Treatment of corticosteroid-resistant ulcerative colitis with oral low molecular weight heparin. World J Gastroenterol 1999; 5(5): 448-450
URL: https://www.wjgnet.com/1007-9327/full/v5/i5/448.htm
DOI: https://dx.doi.org/10.3748/wjg.v5.i5.448